Kevin Cronin Clark - 18 Dec 2025 Form 4 Insider Report for CROSS COUNTRY HEALTHCARE INC (CCRN)

Role: Director
Signature: /s/ Kevin C. Clark
Issuer symbol: CCRN
Transactions as of: 18 Dec 2025
Net transactions value: $0
Form type: 4
Filing time: 22 Dec 2025, 07:18:13 UTC
Previous filing: 03 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Clark Kevin Cronin	Director	C/O CROSS COUNTRY HEALTHCARE, INC., 6551 PARK OF COMMERCE BOULEVARD, N.W., BOCA RATON	/s/ Kevin C. Clark	22 Dec 2025	0001765081

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CCRN	Common Stock	Award	$0	+162,672	+25%	$0.000000	809,170	18 Dec 2025	Direct	F1
holding	CCRN	Common Stock						3,961	18 Dec 2025	By Spouse	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These restricted shares of common stock ("RSAs") vest in three substantially equal installments on each of December 18, 2026, March 31, 2027 and March 31, 2028. The Compensation Committee of the Company's Board of Directors approved the number of RSAs to be granted on December 18, 2025, instead of March 31, 2025, following the termination of the Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc. and Aya Healthcare, Inc. on December 3, 2025. After the initial vesting date 12 months from the grant date, the remaining RSAs will vest on March 31 of the two subsequent years to coincide with the vesting dates of the Company's previously granted RSAs.
F2	Represents shares held by Mr. Clark's spouse. Mr. Clark disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.

Content

These restricted shares of common stock ("RSAs") vest in three substantially equal installments on each of December 18, 2026, March 31, 2027 and March 31, 2028. The Compensation Committee of the Company's Board of Directors approved the number of RSAs to be granted on December 18, 2025, instead of March 31, 2025, following the termination of the Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc. and Aya Healthcare, Inc. on December 3, 2025. After the initial vesting date 12 months from the grant date, the remaining RSAs will vest on March 31 of the two subsequent years to coincide with the vesting dates of the Company's previously granted RSAs.

Represents shares held by Mr. Clark's spouse. Mr. Clark disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.